Skip to main content
. 2021 Feb 15;12(2):e00298. doi: 10.14309/ctg.0000000000000298

Figure 4.

Figure 4.

Therapeutic outcomes per patient at the end of each follow-up year, stratified by predicted response groups. IFX, infliximab; NR, predicted nonresponders; PFR, predicted functional responders.